The immuno-oncology therapy developer has amassed at least $190m of overall funding since emerging out of Stanford University.

The immuno-oncology therapy developer has amassed at least $190m of overall funding following a series B round backed by Lilly Asia Ventures.

The Tata unit has reportedly bought a 55% stake in the Intel Capital-backed digital pharmacy operator, which was valued at $200m as of mid-2019.

Barda Ventures, the investment unit of HHS’s Biomedical Advanced Research and Development Authority, has committed a minimum of $50m.

Blockchain game developer Mythical Games pulled in $75m while enterprise software developer Morning Consult reached a unicorn valuation in an Advance Venture Partners-led round.

Roivant spinoff Datavant is joining forces with medical data technology peer Ciox Health, which counts Merck & Co as an investor.

Helsinki spinout Aiforia has raised an initial $15.4m in series B funding, bringing it halfway to the round’s target.

Agilio Software has bought Newcastle spinout Clarity Informatics, a healthtech developer founded in 2000.

The GV and WuXi AppTec-backed operator of remote laboratory manager has secured $56.1m of new funding from investors including Eli Lilly.

Financial advice service Credit Sesame pushed its overall funding past $160m while small molecule drug developer Genhouse and AI technology developer Gideon Brothers each raised $31m.